Issue 6/2010

To the nucleolar bodies (nucleoli) in cells of the lymphocytic lineage in patients suffering from B – chronic lymphocytic leukemia (495 — 500)

K. SMETANA, J. KARBAN, M. TRNENY

DOI: 10.4149/neo_2010_06_495

Antisense oligonucleotide targeting survivin inhibits growth by inducing apoptosis in human osteosarcoma cells MG-63 (501 — 506)

Y. F. WU, X. J. LIANG, Y. Y. LIU, W. GONG, J. X. LIU, X. P. WANG, Z. Q. ZHUANG, Y. GUO, H. Y. SHEN

DOI: 10.4149/neo_2010_06_501

Better detection of Ig heavy chain and TCRγ gene rearrangement in plasma cell-free DNA from patients with non-Hodgkin Lymphoma (507 — 511)

L. ZHONG, W. F. HUANG

DOI: 10.4149/neo_2010_06_507

CYP and GST polymorphisms and survival in advanced non-small cell lung cancer patients (512 — 521)

A. O. ADA, S. C.KUNAK, F. HANCER, S. BILGEN, S. H. SUZEN, S. ALPAR, M. GULHAN, B. KURT, M. ISCAN

DOI: 10.4149/neo_2010_06_512

Overexpression of AEG-1 in renal cell carcinoma and its correlation with tumor nuclear grade and progression (522 — 529)

W. CHEN, Z. KE, H. SHI, S. YANG, L. WANG

DOI: 10.4149/neo_2010_06_522

The impact of several phenotypic features at diagnosis on survival of patients with myelodysplastic syndromes (530 — 536)

S. C. REIS-ALVES, F. TRAINA, S. T. SAAD, K. METZE, I. LORAND-METZE

DOI: 10.4149/neo_2010_06_530

Optimizing of MALDI-ToF-based low-molecular-weight serum proteome pattern analysis in detection of breast cancer patients; the effect of albumin removal on classification performance. (537 — 544)

M. PIETROWSKA, Ł. MARCZAK, J. POLANSKA, E. NOWICKA, K. BEHRENT, R. TARNAWSKI, M. STOBIECKI, A. POLANSKI, P. WIDLAK

DOI: 10.4149/neo_2010_06_537

Prognostic role of Wnt7a expression in ovarian carcinoma patients (545 — 551)

X. L. ZHANG, C. J. PENG, J. PENG, L. Y. JIANG, X. M. NING, J. H. ZHENG

DOI: 10.4149/neo_2010_06_545

Minimal residual disease detection using real-time quantitative PCR analysis of immunoglobulin and T-cell receptor gene rearrangements in the non-MRD-based ALL IC-BFM 2002 protocol for childhood ALL: Slovak experience. (552 — 561)

A. KOLENOVA, I. HIKKEL, D. ILENCIKOVA, M. HIKKELOVA, D. SEJNOVA, E. KAISEROVA, A. CIZMAR, J. PUSKACOVA, E. BUBANSKA, I. ORAVKINOVA, M. GENCIK

DOI: 10.4149/neo_2010_06_552

Heparanase participates in the growth and invasion of human U-2OS osteosarcoma cells and its close relationship with hypoxia-inducible factor-1α in osteosarcoma (562 — 571)

C. ZENG Z. KE, C. LUO, Z. YANG, L. WANG

DOI: 10.4149/neo_2010_06_562

Survivin: a promising biomarker in breast carcinoma (572 — 577)

M. ADAMKOV, E. HALASOVA, K. KAJO, K. MACHALEKOVA, D. VYBOHOVA, I. VARGA, J. RAJCANY

DOI: 10.4149/neo_2010_06_572

Prognostic factors and treatment outcome in 1,516 adult patients with de novo and secondary acute myeloid leukemia in 1999–2009 in 5 hematology intensive care centers in the Czech Republic (578 — 589)

T. SZOTKOWSKI, J. MUZIK, J. VOGLOVA, V. KOZA, J. MAALOUFOVA, T. KOZAK, M. JAROSOVA, K. MICHALOVA, P. ZAK, K. STEINEROVA, J. VYDRA, M. LANSKA, B. KATRINCSAKOVA, K. SICOVA, T. PAVLIK, L. DUSEK, K. INDRAK

DOI: 10.4149/neo_2010_06_578

Endoglin and CD-34 immunoreactivity in the assessment of microvessel density in normal pituitary and adenoma subtypes (590 — 593)

F. ROTONDO, S. SHARMA, B. W. SCHEITHAUER, E. HORVATH, L. V. SYRO, M. CUSIMANO, F. NASSIRI, G. M. YOUSEF, K. KOVACS

DOI: 10.4149/neo_2010_06_590

Prevalence of high-risk human papillomavirus types (HPV-16, HPV-18) and their physical status in primary laryngeal squamous cell carcinoma (594 — 600)

B. LIU, Z. LU, P. WANG, Z. BASANG, X. RAO

DOI: 10.4149/neo_2010_06_594